Zacks Company Profile for Natus Medical Incorporated (NTUS : NSDQ) |
|
|
|
Company Description |
Natus Medical Incorporated is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and newborn care. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, and software systems for managing and tracking disorders and diseases for public health laboratories.
Number of Employees: 1,400 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $32.57 |
Daily Weekly Monthly
 |
20 Day Moving Average: 1,012,163 shares |
Shares Outstanding: 34.58 (millions) |
Market Capitalization: $1,126.31 (millions) |
Beta: 0.23 |
52 Week High: $33.93 |
52 Week Low: $21.31 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
25.03% |
36.49% |
12 Week |
41.24% |
52.65% |
Year To Date |
37.25% |
62.57% |
|
|
|
|
|
|
|
General Corporate Information |
Officers
Thomas J. Sullivan - Chief Executive Officer and President
Joshua H. Levine - Chairperson
B. Drew Davies - Chief Financial Officer and Executive Vice Preside
Ilan Daskal - Director
Eric J. Guerin - Director
|
|
Peer Information
Natus Medical Incorporated (ABMD)
Natus Medical Incorporated (DMDS)
Natus Medical Incorporated (CPWY.)
Natus Medical Incorporated (EQUR)
Natus Medical Incorporated (ECIA)
Natus Medical Incorporated (FMS)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 639050103
SIC: 3845
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/04/22
|
|
Share - Related Items
Shares Outstanding: 34.58
Most Recent Split Date: (:1)
Beta: 0.23
Market Capitalization: $1,126.31 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 0.00% |
Current Fiscal Quarter EPS Consensus Estimate: $0.32 |
Indicated Annual Dividend: $0.00 |
Current Fiscal Year EPS Consensus Estimate: $1.44 |
Payout Ratio: 0.00 |
Number of Estimates in the Fiscal Year Consensus: 1.00 |
Change In Payout Ratio: 0.00 |
Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
Next EPS Report Date: 08/04/22 |
|
|
|
|